176 - 200 of 5832 Results
Title
Year
- RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s disease2024OPENTitle: RTP801 interacts with the tRNA ligase complex and dysregulates its RNA ligase activity in Alzheimer’s diseaseJournal Name: Nucleic Acids ResearchPublisher: Oxford University Press (OUP)Vol: 52Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/nar/gkae776Citation Count: 0
-
OPENTitle: Understanding what aspects of Parkinson’s disease matter most to patients and familiesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-024-71555-4Citation Count: 1
- Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer2024OPENTitle: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancerJournal Name: Nature MetabolismPublisher: Springer Science and Business Media LLCVol: 6Issue #: 9Start Page: 1695End Page: 1711Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42255-024-01118-4Citation Count: 6
- SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers Initiative2024OPENTitle: SVA Regulation of Transposable Element Clustered Transcription within the Major Histocompatibility Complex Genomic Class II Region of the Parkinson’s Progression Markers InitiativeJournal Name: GenesPublisher: MDPI AGVol: 15Issue #: 9Start Page: 1185End Page: 1185Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes15091185Citation Count: 0
- A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s disease2024OPENTitle: A novel super-resolution microscopy platform for cutaneous alpha-synuclein detection in Parkinson’s diseaseJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2024.1431549Citation Count: 0
- Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials2024OPENTitle: Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII TrialsJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 6Start Page: 1243End Page: 1255Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-240035Citation Count: 0
- Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders2024OPENTitle: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disordersJournal Name: Genetics in MedicinePublisher: Elsevier BVVol:Issue #:Start Page: 101251End Page: 101251Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.gim.2024.101251Citation Count: 0
- Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progression2024OPENTitle: Cohort-specific Boolean models highlight different regulatory modules during Parkinson’s disease progressionJournal Name: iSciencePublisher: Elsevier BVVol: 27Issue #: 10Start Page: 110956End Page: 110956Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2024.110956Citation Count: 0
-
OPENTitle: SynBot is an open-source image analysis software for automated quantification of synapsesJournal Name: Cell Reports MethodsPublisher: Elsevier BVVol: 4Issue #: 9Start Page: 100861End Page: 100861Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.crmeth.2024.100861Citation Count: 6
-
OPENTitle: An Inducible Luminescent System to Explore Parkinson’s Disease-Associated GenesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 17Start Page: 9493End Page: 9493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25179493Best OA location URL: https://doi.org/10.3390/ijms25179493Citation Count: 0
- Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populations2024OPENTitle: Bridging the gap: Multi‐omics profiling of brain tissue in Alzheimer's disease and older controls in multi‐ethnic populationsJournal Name: Alzheimer's & DementiaPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14208Citation Count: 1
- Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s disease2024OPENTitle: Shared and distinct cortical morphometric alterations in five neuropsychiatric symptoms of Parkinson’s diseaseJournal Name: Translational PsychiatryPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41398-024-03070-zCitation Count: 0
- Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM502024OPENTitle: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50Journal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.99914Citation Count: 0
- Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's disease2024OPENTitle: Medication improves velocity, reaction time, and movement time but not amplitude or error during memory‐guided reaching in Parkinson's diseaseJournal Name: Physiological ReportsPublisher: WileyVol: 12Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14814/phy2.16150Citation Count: 0
- Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trial2024OPENTitle: Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson’s disease, results from a phase II randomised controlled trialJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 8Start Page: e0309217End Page: e0309217Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0309217Citation Count: 0
-
OPENTitle: Blood‐based multivariate methylation risk score for cognitive impairment and dementiaJournal Name: Alzheimer's & DementiaPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14061Best OA location URL: https://doi.org/10.1002/alz.14061Citation Count: 2
- Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein Fibrils2024OPENTitle: Single-Molecule Fingerprinting Reveals Different Growth Mechanisms in Seed Amplification Assays for Different Polymorphs of α-Synuclein FibrilsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 18Start Page: 3270End Page: 3285Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00185Citation Count: 0
- Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PD2024OPENTitle: Acceptability of digital health technologies in early Parkinson's disease: lessons from WATCH-PDJournal Name: Frontiers in Digital HealthPublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fdgth.2024.1435693Citation Count: 0
-
OPENTitle: Dynamic balance and gait impairments in Parkinson’s disease: novel cholinergic patternsJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/braincomms/fcae286Citation Count: 0
- Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formation2024OPENTitle: Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formationJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-024-06751-zCitation Count: 0
- Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification Trials2024OPENTitle: Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early‐ to Mid‐Stage Parkinson's Disease Modification TrialsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 11Start Page: 1345End Page: 1354Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.14191Citation Count: 0
-
OPENTitle: IAPP - oligomerisation levels in plasma of people with type 2 diabetesJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-70255-3Citation Count: 0
- Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers2024OPENTitle: Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00763-6Citation Count: 0
- Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies2024OPENTitle: Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologiesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 385Issue #: 6711Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm6131Best OA location URL: https://doi.org/10.1101/2024.06.23.598940Citation Count: 18
- Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits2024OPENTitle: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficitsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 34Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adn6016Citation Count: 4